Skip to main content

Carbohydrate Structural Characterization of Fas Ligand Inhibitory Protein

  • Protocol
Therapeutic Proteins

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 308))

  • 2160 Accesses

Abstract

Decoy receptor 3 (DcR3) is a novel member of the tumor necrosis factor (TNF) receptor superfamily that plays an important role in regulating apoptosis in normal physiology (15). The engineered (Arg218Gln) soluble form of DcR3 was termed Fas ligand inhibitory protein (FLINT; LY498919) in an effort to create a molecule that was less susceptible to proteolysis (5). FLINT, expressed in Chinese ovary (CHO) cells, is a therapeutic glycoprotein with 271 amino acid residues, 10 disulfide bonds, 1 potential N-glycosylation site, and 2 potential O-glycosylation sites. Oligosaccharide structures strongly influence FLINT pharmacokentics (6). Hence, it is essential to characterize carbohydrate structures of FLINT in routine testing to monitor batch-to-batch consistency. There are many ways to characterize the carbohydrate structures of a glycoprotein. In this chapter, we will describe routine carbohydrate characterization of FLINT to monitor its batch-to-batch consistency. The methods include (1) neutral and amino monosaccharide composition analysis; (2) sialic acid content assay; and (3) oligosaccharide profiling by weak-anion exchange (WAX) high performance liquid chromatography (HPLC) with fluorescence detection, and additional glycosylation characterization, including site mapping and oligosaccharide structural elucidation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kramer, P. H., Behrmann, I., Dhein, J., and Debatin, K. M. (1994) Regulation of apoptosis in the immune system. Curr. Opin. Immunol. 64, 279–289.

    Article  Google Scholar 

  2. Yu, K.-Y., Kwon, B., Ni, J., Zhai, Y., Ebner, R., and Kwon, B. S. (1999) A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHTmediated apoptosis. J. Biol. Chem. 274, 13733–13736.

    Article  PubMed  CAS  Google Scholar 

  3. Zhang, J., Salcedo, T. W., Wan, X., Ullrich, S., Hu, B., Gregorio, T., et al. (2001) Modulation of T-cell responses to alloantigens by TR6/DcR3. J. Clin. Investig. 107, 1459–1468.

    Article  PubMed  CAS  Google Scholar 

  4. Wroblewski, V. J., Witcher, D. R., Becker, G. W., Davis, K. A., Dou, S., Micanovic, R., et al. (2003) Decoy receptor 3 (DcR3) is proteolytically processed to a metabolic fragment having differential activities against Fas ligand and LIGHT. Biochem. Pharmacol. 65, 657–677.

    Article  PubMed  CAS  Google Scholar 

  5. Wroblewski, V. J., McCloud, C., Davis, K. A., Manetta, J., Micanovic, R., and Witcher, D. R. (2003) Pharmacokinetics, metabolic stability, and subcutaneous bioavailability of a genetically engineered analog of DcR3, FLINT [DcR3(R218Q)], in cynomolgus monkeys and mice. Drug Metab. Disp. 31, 502–507.

    Article  CAS  Google Scholar 

  6. Jenkins, N., Witcher, D. R., and Wroblewski, V. J. (2002) Enhancing sialic acid content of FLINT (Fas ligand inhibitory protein) R218Q with improved protease-resistance by having additional glycosylation sites engineered into the native FLINT sequence. WO 2002060949. 42 pp.

    Google Scholar 

  7. Rocklin, R. D., Clarke, A. P., and Weitzhandler, M. (1998) Improved long-term reproducibility for pulsed amperometric detection of carbohydrates via a new quadruple-potential waveform. Anal. Chem. 70, 1496–1501.

    Article  CAS  Google Scholar 

  8. Carr, S. A., Huddleston, M. J., and Bean, M. F. (1993) Selective identification and differentiation of N-and O-linked oligosaccharides in glycoproteins by liquid chromatographymass spectrometry. Protein Sci. 2, 183–196.

    Article  PubMed  CAS  Google Scholar 

  9. Huddleston, M. J., Bean, M. F., and Carr, S. A. (1993) Collisional fragmentation of glycopeptides by electrospray ionization LC/MS and LC/MS/MS: methods for selective detection of glycopeptides in progress digests. Anal. Chem. 65, 877–884.

    Article  PubMed  CAS  Google Scholar 

  10. Spellman, M. W., Leonard, C. K., Basa, L. J., Gelineo, I., and van Halbeek, H. (1991) Carbohydrate structures of recombinant soluble human CD4 expressed in Chinese hamster ovary cells. Biochemistry 30, 2395–2406.

    Article  PubMed  CAS  Google Scholar 

  11. Spellman, M. W., Basa, L. J., Leonard, C. K., et al. (1989) Carbohydrate structures of human tissue plasminogen activator expressed in Chinese hamster ovary cells. J. Biol. Chem. 264, 14,100–14,111.

    PubMed  CAS  Google Scholar 

  12. Watson, E., Bhide, A., and van Halbeek, H. (1994) Structure determination of the intact major sialylated oligosaccharide chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells. Glycobiology 4, 227–237.

    Article  PubMed  CAS  Google Scholar 

  13. Amoresano, A., Siciliano, R., Orru, S., Napoleoni, R., Altarocca, V., De Luca, E., et al. (1996) Structural characterisation of human recombinant glycohormones follitropin, lutropin and choriogonadotropin expressed in Chinese hamster ovary cells. Eur. J. Biochem. 242, 608–618.

    Article  PubMed  CAS  Google Scholar 

  14. Fan, J. Q., Yamamoto, K., Kumagai, H., and Tochikura., T. (1990) Induction and efficient purification of endo-alpha-N-acetyl-D-galactosaminidase from Alcaligenes sp. Agric. Biol. Chem. 54, 233–234.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Humana Press Inc.

About this protocol

Cite this protocol

Huang, L., Mitchell, C.E., Yu, L., Gough, P.C., Riggin, A. (2005). Carbohydrate Structural Characterization of Fas Ligand Inhibitory Protein. In: Smales, C.M., James, D.C. (eds) Therapeutic Proteins. Methods in Molecular Biology™, vol 308. Humana Press. https://doi.org/10.1385/1-59259-922-2:421

Download citation

  • DOI: https://doi.org/10.1385/1-59259-922-2:421

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-390-9

  • Online ISBN: 978-1-59259-922-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics